Eli Lilly
LLY
LLY
2,661 hedge funds and large institutions have $288B invested in Eli Lilly in 2022 Q4 according to their latest regulatory filings, with 325 funds opening new positions, 950 increasing their positions, 1,006 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6% less repeat investments, than reductions
Existing positions increased: 950 | Existing positions reduced: 1,006
10% less call options, than puts
Call options by funds: $2.38B | Put options by funds: $2.64B
3.66% less ownership
Funds ownership: 83.64% → 79.99% (-3.7%)
Holders
2,661
Holding in Top 10
198
Calls
$2.38B
Puts
$2.64B
Top Buyers
| 1 | +$1.35B | |
| 2 | +$637M | |
| 3 | +$461M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$446M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$313M |
Top Sellers
| 1 | -$1.39B | |
| 2 | -$794M | |
| 3 | -$777M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$671M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$505M |